Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Frezza

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Ecancermedicalscience|May 13, 2016
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case reportAntonio Ungaro, Franco Orsi, Chiara Casadio, et al.
BMC Cancer|April 18, 2015
Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitisOlga Venditti, Delia De Lisi, Marco Caricato, et al.
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
Pediatric Blood & Cancer|April 21, 2015
Primary cutaneous and subcutaneous Ewing sarcomaAngela Di Giannatale, Anna Maria Frezza, Marie-Cécile Le Deley, et al.
Annals of Surgical Oncology|January 9, 2022
Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single InstitutionMaria Danieli, Francesco Barretta, Marco Fiore, et al.
Cancer|July 15, 2023
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wallMaria Danieli, Francesco Barretta, Stefano Radaelli, et al.
Oncotarget|September 30, 2015
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysisBruno Vincenzi, Margherita Nannini, Elena Fumagalli, et al.
Annals of Surgical Oncology|June 24, 2020
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma GroupAnna Paioli, Silvia Stacchiotti, Domenico Campanacci, et al.
Oncotarget|April 19, 2015
Deregulation of dicer and mir-155 expression in liposarcomaBruno Vincenzi, Michele Iuliani, Alice Zoccoli, et al.
Journal of Cellular Physiology|June 17, 2011
PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapyBruno Vincenzi, Daniele Santini, Gaia Schiavon, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Ecancermedicalscience|May 13, 2016
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case reportAntonio Ungaro, Franco Orsi, Chiara Casadio, et al.
BMC Cancer|April 18, 2015
Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitisOlga Venditti, Delia De Lisi, Marco Caricato, et al.
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
Pediatric Blood & Cancer|April 21, 2015
Primary cutaneous and subcutaneous Ewing sarcomaAngela Di Giannatale, Anna Maria Frezza, Marie-Cécile Le Deley, et al.
Annals of Surgical Oncology|January 9, 2022
Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single InstitutionMaria Danieli, Francesco Barretta, Marco Fiore, et al.
Cancer|July 15, 2023
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wallMaria Danieli, Francesco Barretta, Stefano Radaelli, et al.
Oncotarget|September 30, 2015
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysisBruno Vincenzi, Margherita Nannini, Elena Fumagalli, et al.
Annals of Surgical Oncology|June 24, 2020
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma GroupAnna Paioli, Silvia Stacchiotti, Domenico Campanacci, et al.
Oncotarget|April 19, 2015
Deregulation of dicer and mir-155 expression in liposarcomaBruno Vincenzi, Michele Iuliani, Alice Zoccoli, et al.
Journal of Cellular Physiology|June 17, 2011
PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapyBruno Vincenzi, Daniele Santini, Gaia Schiavon, et al.
Pageof 7